Study guide
4.4 Legitimate Medical Purpose, Corresponding Responsibility & Red Flags
Utah MPJE Pharmacy Jurisprudence Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Utah Pharmacy Regulatory Framework, Facility Licensing & the PIC
1.1 DOPL, the Utah State Board of Pharmacy & the Sources of Utah Pharmacy Law 1.2 Federal vs. Utah Law: Following the Stricter Standard 1.3 Utah Pharmacy License Classes (A–E) & Facility Licensing 1.4 The Pharmacist-in-Charge (PIC): Duties, Self-Audits & Notifications 1.5 Facility Inspections, Ownership & Location Changes, Closing & Facility Discipline
2 Chapter 2: Pharmacist, Intern & Technician Licensure and Personnel
2.1 Pharmacist Licensure, the NAPLEX & Utah MPJE, and Licensure by Endorsement 2.2 License Renewal, Continuing Education & Reinstatement 2.3 Pharmacy Interns & Preceptors 2.4 Pharmacy Technicians, Technician Trainees & Supportive Personnel
3 Chapter 3: Unlawful & Unprofessional Conduct, Discipline, and Impairment
3.1 Unlawful Conduct, Criminal Penalties, Fines & the Disciplinary Process 3.2 Unprofessional Conduct, the APhA Code of Ethics & Utah's Conscience Law 3.3 Impairment, the Utah Professionals Health Program & Reinstatement
4 Chapter 4: Prescription Issuance, Prescriber Authority & Electronic Prescribing
4.1 Prescriber Scope of Authority in Utah 4.2 Required Prescription Elements, Oral & Faxed Orders, and Alterations 4.3 Mandatory Electronic Prescribing of Controlled Substances (EPCS) in Utah 4.4 Legitimate Medical Purpose, Corresponding Responsibility & Red Flags
5 Chapter 5: Patient Counseling, Prospective DUR, Confidentiality & Records
5.1 Patient Counseling: The Offer, Who May Counsel & Delivered Prescriptions 5.2 Prospective Drug Utilization Review & Patient Medication Profiles 5.3 Confidentiality, HIPAA & Protected Health Information 5.4 Pharmacy Records, Retention Periods & Facility Operating Standards
6 Chapter 6: Expanded Practice: Collaboration, Pharmacist Prescribing & Drug Administration
6.1 Collaborative Pharmacy Practice, Drug Therapy Management & Administration of Drugs 6.2 Self-Administered Hormonal Contraception: Standing Order & Pharmacist Prescribing 6.3 Pharmacist Prescribing Under Utah Code § 58-17b-627: Tobacco Cessation, HIV PrEP/PEP, Fluoride & Epinephrine 6.4 Vaccine Administration: DOPL's Protocol, Delegation, Emergencies & USIIS Reporting
7 Chapter 7: Opioid Overdose Prevention, Emergency Refills & Returned or Donated Drugs
7.1 Naloxone & Opioid-Safety Laws in Utah 7.2 Emergency Refills, Combined Refills & Insulin Continuity 7.3 Returned Drugs, Consumer Disposal & the Charitable Prescription Drug Recycling Program
8 Chapter 8: Controlled Substance Schedules, Registration & Security in Utah
8.1 Controlled Substance Schedules: Federal CSA & Utah-Specific Scheduling 8.2 DEA Registration & Facility Licensing 8.3 Controlled Substance Storage & Physical Security
9 Chapter 9: Dispensing Controlled Substances & the Utah Controlled Substance Database
9.1 Schedule II Prescriptions: 30-Day Window, One-Month Supply, Multiple Prescriptions & the 7-Day Acute Limit 9.2 Schedule II Partial Fills, Emergency Oral Orders & Methadone Emergency Orders 9.3 Schedule III–V Prescriptions: Refill Limits, the 80% Rule & Controlled Substance Transfers 9.4 The Utah Controlled Substance Database (CSD)
10 Chapter 10: Dispensing Standards: Labeling, Substitution, Refills, Packaging, Product Integrity & OTC Products
10.1 Prescription Labels: Utah Minimum Elements, Controlled Substance & Opioid Warnings, and Special Labels 10.2 Drug Product Selection: Generic Equivalents, Therapeutically Similar Drugs & Interchangeable Biologics 10.3 Legend-Drug Prescription Validity, Refills & Transfers 10.4 Poison Prevention Packaging Act (PPPA) & Special Packaging 10.5 Drug Product Conditions That Prohibit Dispensing: Adulterated, Misbranded, Outdated, Recalled & Suspect Products 10.6 Nonprescription Products: OTC Labeling & Packaging, Pseudoephedrine, Iodine, Schedule V & Other Restricted OTC Sales
11 Chapter 11: Acquisition, Inventory, Loss, Distribution & Delivery
11.1 Ordering Schedule II Substances: DEA Form 222 & CSOS 11.2 Controlled Substance Inventories & Utah's Schedule II Perpetual Inventory 11.3 Theft, Significant Loss & Disposal of Controlled Substances 11.4 Drug Acquisition & Distribution, Office-Use Sales, and Delivering Prescriptions to Patients
12 Chapter 12: Compounding Standards, USP Chapters & Hazardous Drugs
12.1 Non-Sterile Compounding & USP <795> Standards 12.2 Sterile Compounding & USP <797> Standards 12.3 Hazardous Drug Handling & USP <800> Standards
13 Chapter 13: Institutional, Central Processing, Remote Dispensing, Specialty Outlets & Automation
13.1 Institutional Practice: Hospitals, Pharmaceutical Administration Facilities & Emergency Drug Kits 13.2 Centralized Prescription Processing, Telepharmacy & Remote Dispensing Pharmacies 13.3 Nuclear Pharmacies, Class E Outlets & Dispensing Medical Practitioners 13.4 Automated Pharmacy Systems, Quality Assurance & Pharmacy Audits
4.4 Legitimate Medical Purpose, Corresponding Responsibility & Red Flags
Key Takeaways Explain This Topic AI
Under 21 CFR 1306.04(a), a controlled substance prescription must be issued for a legitimate medical purpose by a practitioner acting in the usual course of professional practice, and the pharmacist has a corresponding responsibility.
Knowingly filling an invalid controlled substance prescription exposes the pharmacist to the same federal penalties as distributing without a prescription.
Dispensing to a person the pharmacist knows or should know is trying to obtain drugs by fraud is a third degree felony in Utah (Utah Code §§ 58-17b-501(11), 58-17b-504(1)).
If a Utah dispenser's CSD review suggests a patient is getting opioids in inconsistent quantities or frequencies, the dispenser must reasonably attempt to contact the prescriber (Utah Code § 58-37f-304(4)).
A prescriber's confirmation that a prescription is authentic does not by itself resolve red flags suggesting it lacks a legitimate medical purpose.
Last updated: September 2026
4.4 Legitimate Medical Purpose, Corresponding Responsibility & Red Flags
Blueprint item 3.1 asks candidates to determine "whether prescriptions/drug orders are issued for a legitimate medical purpose, and within all applicable restrictions." This is where federal and Utah law meet most directly.
The federal rule (21 CFR 1306.04)
"A prescription for a controlled substance to be effective must be issued for a legitimate medical purpose by an individual practitioner acting in the usual course of his professional practice. The responsibility for the proper prescribing and dispensing of controlled substances is upon the prescribing practitioner, but a corresponding responsibility rests with the pharmacist who fills the prescription."
A prescription that fails either test (legitimate medical purpose or usual course of practice) is not a valid prescription . A person who knowingly fills it is treated as distributing a controlled substance without a prescription.
"Knowingly" can include deliberately ignoring obvious warning signs. Courts treat willful blindness as knowledge, and DEA revocation decisions cite pharmacies that filled prescriptions despite unresolved red flags.
The pharmacist also has a separate duty to fill prescriptions only in the usual course of professional pharmacy practice (21 CFR 1306.06).
Utah provisions
Provision What it adds
§ 58-17b-501(11); § 58-17b-504(1) Dispensing to a person you know or should know is attempting to obtain drugs by fraud or misrepresentation is unlawful conduct and a third degree felony
§ 58-17b-501(6) Obtaining drugs, or helping someone else obtain them, by fraud, forgery, alteration, concealment, or false statement is unlawful
§ 58-37-304(10) A practitioner may not prescribe or dispense to someone known to be using a false name or address to obtain a controlled substance
§ 58-37f-304(4) If the dispenser's CSD review suggests a patient is obtaining opioids in inconsistent quantities or frequencies, the dispenser must reasonably attempt to contact the prescriber for an informed, current professional decision on whether the opioid is medically justified
R156-37-502(4)–(6) Failing to keep effective controls against diversion, failing to account for shortages, or supplying a drug-dependent person without a legitimate medical purpose is unprofessional conduct
R156-37f-203(4); R156-37f-102(13) CSD submissions include identification data for the person picking up a controlled substance (ID type, number, issuing state, and name). "Positive identification" means a government photo ID, or a documented alternative when the person has none.
Utah does not require pharmacists to query the CSD before every controlled substance fill. The mandatory checks in § 58-37f-304(2) fall on prescribers (before the first Schedule II or III opioid prescription and periodically after that). Checking the CSD when red flags appear is still a key part of due diligence. Accessing and reviewing the database in accordance with the chapter carries civil immunity (§ 58-37f-701).
Recognizing red flags
Category Examples
Patient Long travel distance to the prescriber or pharmacy; paying cash despite having insurance; insisting on a specific brand or color of tablet; early refill requests; repeated "lost" or "stolen" medication; appearing impaired
Prescriber Many patients with identical high-dose regimens; prescribing outside specialty; prescriber far from the patient; unusually high volume of controlled prescriptions
Prescription Alterations; missing elements; unusual quantities or directions; "cocktail" combinations such as an opioid with a benzodiazepine and carisoprodol
CSD history Multiple prescribers or pharmacies for overlapping controlled substances; escalating doses; concurrent high-risk prescriptions
Utah law also addresses high-risk prescriptions : an opiate or benzodiazepine written to continue for more than 30 consecutive days. Before issuing one, a prescriber must check the CSD for another active high-risk prescription from a different practitioner, and if one exists, must consult that practitioner and document why multiple high-risk prescriptions are needed (§ 58-37-305). Prescribers must also discuss risks with patients before an initial opiate prescription, and offer an opiate antagonist in certain cases (§ 58-37-306; see Section 7.1).
A due-diligence workflow
Look at the prescription. Check completeness, alterations, the prescriber's scope and DEA registration, and Utah limits such as the 30-day CII presentation window and the 7-day acute-opiate limit.
Review the history. Check the pharmacy profile and the CSD.
Talk to the patient. Ask about diagnosis, prior therapy, and why they are using this pharmacy.
Contact the prescriber. Ask for clinical context (diagnosis, treatment plan, reason for the dose or combination), not just "did you write this?"
Decide and document. Record what you checked, who you spoke with, and why you filled or refused.
If red flags remain unresolved, refuse to fill. The corresponding responsibility is personal, and an employer's or prescriber's insistence does not transfer it.
A pharmacist who refuses to fill should still act professionally. Return a paper prescription to the patient where appropriate, and do not alter or destroy it. Report suspected forgery to law enforcement as appropriate.